Suitable for long term use
For patients to get the full therapeutic benefit, regular usage of Dymista® nasal spray is essential and Dymista® is suitable for long-term use.7
Treatment should be continued for as long as the patient is exposed to the allergen(s).7
Adverse events: Include epistaxis, headache, dysgeusia and unpleasant smell. Hypersensitivity reactions include anaphylactic reactions, angioedema, bronchospasm, glaucoma, increased intraocular pressure, cataract, blurred vision, septal perforation, nasal irritation, nasal ulcers, throat irritation, nausea, dizziness, sleepiness, fatigue, rash, dry mouth and growth retardation may be possible in adolescents receiving prolonged treatment and growth should be monitored regularly.7
Warnings and precautions: Avoid concomitant use with ritonavir. Systemic effects of nasal corticosteroids may occur. Systemic exposure in severe liver disease may be increased. Monitor patients who experience changes in vision or have a history of ocular pressure, glaucoma and/or cataract. If adrenal function is impaired, take care when changing medication to Dymista®. In patients with infections, recent surgery or injury to nose or mouth, weigh benefits against the risks of use.7
Consult the Summary of Product Characteristics (SmPC) for more information.